Ozone Generator Syringe for Minimally Invasive Disc Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for back joint disc or tendon pain, such as sciatica and arthritis, often involve invasive procedures with drawbacks like irreversibility, scar tissue formation, slower recovery, longer hospital stays, and infection risks, while existing minimally invasive methods are costly and lack efficient delivery of therapeutic agents like oxygen-ozone mixtures.

Innovation Solution

A portable handheld apparatus for administering therapeutic agents, such as oxygen-ozone mixtures, using a material treatment module that generates ozone or excited oxygen on demand, allowing for efficient, sterile, and point-of-use application directly to affected areas.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surgical intervention is used to treat severe disc herniation, then pain relief and herniation removal are achieved, but irreversibility, scar tissue formation, slower recovery, longer hospital stays, and infection risks occur

Engineering Contradiction:
Improvepain relief effectivenessVSAvoidinfection risk and scar tissue formation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the herniated disc material through a minimally invasive percutaneous needle approach, avoiding open surgical incisions. The needle is inserted through the skin and targeted directly at the herniated nucleus pulposus, which is then aspirated or decompressed, achieving pain relief without creating large wounds that lead to scar tissue or infection

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces an intermediary substance (ozone gas or oxygen-ozone mixture) that is injected into the disc space through the needle. This intermediary agent creates chemical reactions that reduce inflammation, decrease disc pressure, and promote healing, thereby achieving therapeutic effects without requiring extensive surgical intervention that would increase infection risk

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of time

If minimally invasive percutaneous procedures are used to treat disc herniation, then recovery time is reduced and infection risk is minimized, but treatment costs increase

Engineering Contradiction:
Improverecovery timeVSAvoidtreatment cost
Core Design Contradiction:
Loss of timeVSEase of manufacture

Solution Approach 1:

The invention employs a self-contained handheld apparatus that integrates all necessary components (needle, ozone generation, injection mechanism) into a single portable device. This eliminates the need for expensive hospital infrastructure, specialized surgical suites, and extensive support staff, thereby reducing treatment costs while maintaining rapid recovery benefits through the minimally invasive approach

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If conventional treatments like rest and inactivity are used for mild disc herniation, then infection risk and cost are reduced, but recovery time extends over an extended period

Engineering Contradiction:
Improveinfection riskVSAvoidrecovery time
Core Design Contradiction:
Object-affected harmful factorsVSLoss of time

Solution Approach 1:

The invention performs preliminary therapeutic action by injecting ozone or oxygen-ozone mixture into the disc space before significant inflammation or permanent damage occurs. This proactive treatment addresses mild herniations early, accelerating recovery without requiring extended rest periods, while the minimally invasive nature maintains low infection risk

Inventive Principle:
Principle #10Preliminary action

4Reliability

If repeated steroid or lidocaine injections are administered to inflamed tissue, then inflammation is reduced and pain is relieved, but infection risk and gastric ulcer bleeding risk increase

Engineering Contradiction:
Improveinflammation reductionVSAvoidinfection risk and gastric ulcer bleeding
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention changes the chemical parameter of the injected substance from conventional steroids or lidocaine to ozone gas or oxygen-ozone mixture. This parameter change provides anti-inflammatory and analgesic effects through different mechanisms (oxidative reactions, immune modulation) that do not carry the same risks of infection or gastric ulcer bleeding associated with repeated corticosteroid use

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The apparatus enables efficient and sterile administration of therapeutic agents, reducing recovery time, minimizing complications, and providing anti-infective and analgesic benefits, thereby addressing the limitations of existing treatments for disc herniation and inflammatory conditions.

Implementation Method 1

a material treatment module that generates ozone or excited oxygen on demand

Methodology Applied
Scientific EffectOzone generation: Ozone

Implementation Method 2

The material treatment module may be an electrochemical cell comprising a cathode, an anode, and an electrolyte

Methodology Applied
Scientific EffectElectrochemical reaction: Electrolysis

Implementation Method 3

The treated material is then dispensed out of the device through the needle into the body

Methodology Applied
Scientific EffectPressure-driven flow: Pressure Gradient

Data Source

PatentUS8066659B2Apparatus and method for treating and dispensing a material into tissue
Publication Date: 2011.11.29 ACTIVEO
  • US8066659B2 patent drawing
  • US8066659B2 patent drawing
  • US8066659B2 patent drawing

AI summary

An apparatus for administering a therapeutic is provided. In various embodiments, the apparatus includes a syringe having a barrel and a plunger and having a material treatment module associated therewith. The material treatment module may be an ozone generator that is initiated such that material containing ozone accumulates within the barrel. The material can then be delivered from the barrel into a target site via a needle, thereby delivering therapeutic effects to that target site.